Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
NOVAVAX INC
| Metric | NOVAVAX INC NVAXHealthcare |
|---|---|
| Quality Score | 54 / 100 |
| Revenue (latest) | $1.12B |
| Net income (latest) | $440M |
| Operating margin | 40.3% |
| Net margin | 39.2% |
| Return on equity | −344.7% |
| Return on assets | 37.4% |
| Return on capital (ROCE) | 63.2% |
| Debt / equity | — |
| Revenue growth (YoY) | 64.7% |
| Altman Z″ (distress) | -7.28 |
| Accruals / assets | 58.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.